[pp.int.general] Pharm Companies to ignore MRSA cure over patents?

Peter Liddell pj.liddell at googlemail.com
Mon Aug 13 18:13:15 CEST 2007

"Nonetheless, few Western companies have so far ventured into the field of
bacteriophage therapy.

Dr Nick Housby of Novolytics Limited - one firm which has - says this is
because of the intellectual property rights surrounding the therapy, which
has so long been used elsewhere. Phages are notoriously hard to patent, the
process by which drug companies secure their future profits."

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.pirateweb.net/pipermail/pp.international.general/attachments/20070813/387952ab/attachment.htm 

More information about the pp.international.general mailing list